Correction to: Low to moderate-dose off-label use of second-generation antipsychotics seems to be safe in the light of cardiac adverse effects in child psychiatric patients
Kirsi Kakko, Raili Salmelin, Kaija Puura, Tuija Poutanen
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmaceutical studies and practices · Cardiac electrophysiology and arrhythmias · Cardiovascular Syncope and Autonomic Disorders
Correction to: European Journal of Pediatrics (2025) 184:609
10.1007/s00431-025-06447-4
It has come to our attention that an error occurred in the author names section of the above-mentioned article. The published author list incorrectly presented the family name before the first name for all authors.
The incorrect author list appeared as: Kakko Kirsi · Salmelin Raili · Puura Kaija · Poutanen Tuija.
The correct author list should read: Kirsi Kakko · Raili Salmelin · Kaija Puura · Tuija Poutanen.
Consequently, the article is currently cited as 'Kirsi et al.' instead of the correct 'Kakko et al.'
The publisher sincerely apologizes for this error and any inconvenience it may have caused to the authors and readers.
The original article has been corrected.